CPLANE2
gene geneOn this page
Also known as MGC10731
Summary
CPLANE2 (ciliogenesis and planar polarity effector complex subunit 2, HGNC:28127) is a protein-coding gene on chromosome 1p36.13, encoding Ciliogenesis and planar polarity effector 2 (Q9BU20). Required for efficient primary cilia initiation, regulating a late step in cilia initiation.
Predicted to enable GTP binding activity. Predicted to be involved in cilium assembly; protein localization; and regulation of vesicle-mediated transport. Predicted to act upstream of or within several processes, including axoneme assembly; endocardial cushion fusion; and regulation of smoothened signaling pathway. Located in centriole; ciliary basal body; and ciliary transition zone.
Source: NCBI Gene 79363 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 64 total
- MANE Select transcript:
NM_030907
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28127 |
| Approved symbol | CPLANE2 |
| Name | ciliogenesis and planar polarity effector complex subunit 2 |
| Location | 1p36.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC10731 |
| Ensembl gene | ENSG00000132881 |
| Ensembl biotype | protein_coding |
| OMIM | 620487 |
| Entrez | 79363 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000375599, ENST00000434014, ENST00000945441
RefSeq mRNA: 1 — MANE Select: NM_030907
NM_030907
CCDS: CCDS171
Canonical transcript exons
ENST00000375599 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000906126 | 16232893 | 16233017 |
| ENSE00001161042 | 16231692 | 16232297 |
| ENSE00001679186 | 16232510 | 16232646 |
| ENSE00001819719 | 16236631 | 16237183 |
| ENSE00003605348 | 16233612 | 16233764 |
Expression profiles
Bgee: expression breadth ubiquitous, 167 present calls, max score 88.88.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.2237 / max 43.4608, expressed in 1190 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 10532 | 2.2237 | 1190 |
Top tissues by expression
283 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 88.88 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 78.66 | gold quality |
| cingulate cortex | UBERON:0003027 | 78.65 | gold quality |
| stromal cell of endometrium | CL:0002255 | 78.64 | gold quality |
| prefrontal cortex | UBERON:0000451 | 78.45 | gold quality |
| type B pancreatic cell | CL:0000169 | 78.07 | gold quality |
| olfactory bulb | UBERON:0002264 | 77.87 | gold quality |
| right adrenal gland | UBERON:0001233 | 76.93 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 76.65 | gold quality |
| right uterine tube | UBERON:0001302 | 76.23 | gold quality |
| right frontal lobe | UBERON:0002810 | 75.95 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 75.73 | gold quality |
| adenohypophysis | UBERON:0002196 | 75.67 | gold quality |
| left adrenal gland | UBERON:0001234 | 75.63 | gold quality |
| amygdala | UBERON:0001876 | 75.43 | gold quality |
| nucleus accumbens | UBERON:0001882 | 75.13 | gold quality |
| left ovary | UBERON:0002119 | 73.72 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 73.70 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 73.55 | gold quality |
| caudate nucleus | UBERON:0001873 | 73.50 | gold quality |
| adrenal cortex | UBERON:0001235 | 73.44 | gold quality |
| right ovary | UBERON:0002118 | 73.23 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 73.05 | gold quality |
| apex of heart | UBERON:0002098 | 73.03 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 73.03 | gold quality |
| lower esophagus | UBERON:0013473 | 73.02 | gold quality |
| mucosa of stomach | UBERON:0001199 | 73.01 | gold quality |
| adrenal gland | UBERON:0002369 | 72.97 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 72.94 | gold quality |
| neocortex | UBERON:0001950 | 72.80 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.34 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
14 targeting CPLANE2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6756-5P | 99.82 | 67.97 | 2466 |
| HSA-MIR-6842-5P | 99.80 | 67.54 | 1587 |
| HSA-MIR-7110-5P | 99.80 | 67.84 | 1712 |
| HSA-MIR-6752-3P | 99.72 | 66.71 | 1587 |
| HSA-MIR-6766-5P | 99.68 | 67.70 | 2325 |
| HSA-MIR-10393-5P | 99.65 | 68.01 | 1368 |
| HSA-MIR-6506-5P | 99.04 | 65.66 | 1386 |
| HSA-MIR-2276-3P | 98.76 | 67.75 | 1384 |
| HSA-MIR-619-5P | 98.57 | 64.97 | 1988 |
| HSA-MIR-548AO-5P | 98.55 | 69.57 | 1362 |
| HSA-MIR-548AX | 98.55 | 69.58 | 1362 |
| HSA-MIR-5196-3P | 97.57 | 65.98 | 979 |
| HSA-MIR-4661-3P | 96.81 | 66.02 | 342 |
| HSA-MIR-3918 | 96.13 | 64.65 | 1300 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | cplane2 | ENSDARG00000028442 |
| mus_musculus | Cplane2 | ENSMUSG00000073733 |
| rattus_norvegicus | LOC120103024 | ENSRNOG00000023346 |
Protein
Protein identifiers
Ciliogenesis and planar polarity effector 2 — Q9BU20 (reviewed: Q9BU20)
Alternative names: REM2- and Rab-like small GTPase 1
All UniProt accessions (2): Q9BU20, H0Y6L8
UniProt curated annotations — full annotation on UniProt →
Function. Required for efficient primary cilia initiation, regulating a late step in cilia initiation. Plays a role in the final maturation of the mother centriole and ciliary vesicle that allows extension of the ciliary axoneme.
Subunit / interactions. Interacts with FUZ. Associates with the CPLANE (ciliogenesis and planar polarity effectors) complex via its interaction with FUZ.
Subcellular location. Cytoplasm. Cytoskeleton. Cilium basal body. Microtubule organizing center. Centrosome. Centriole.
Similarity. Belongs to the small GTPase superfamily. Rab family.
RefSeq proteins (1): NP_112169* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001806 | Small_GTPase | Family |
| IPR027417 | P-loop_NTPase | Homologous_superfamily |
| IPR039677 | RSG1 | Family |
Pfam: PF00071
UniProt features (16 total): binding site 12, sequence variant 2, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BU20-F1 | 90.38 | 0.71 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (12): 87; 176; 178; 206; 64; 65; 67; 68; 69; 70; 82; 84
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 102 (showing top):
GOBP_REGULATION_OF_VESICLE_FUSION, GOBP_VESICLE_ORGANIZATION, GOBP_ENDOCARDIAL_CUSHION_DEVELOPMENT, GOBP_MEMBRANE_FUSION, GOBP_REGULATION_OF_EXOCYTOSIS, GOBP_VESICLE_MEDIATED_TRANSPORT, GOBP_ENDOCARDIAL_CUSHION_MORPHOGENESIS, GOCC_MICROTUBULE_ORGANIZING_CENTER, GOBP_REGULATION_OF_VESICLE_MEDIATED_TRANSPORT, GOBP_CELL_CELL_ADHESION, GOBP_EXOCYTOSIS, GOBP_ANIMAL_ORGAN_MORPHOGENESIS, GOBP_PROTEIN_MATURATION, GOBP_ORGANELLE_MEMBRANE_FUSION, GOBP_HEART_MORPHOGENESIS
GO Biological Process (15): endocardial cushion fusion (GO:0003274), exocytosis (GO:0006887), smoothened signaling pathway (GO:0007224), intracellular protein localization (GO:0008104), regulation of smoothened signaling pathway (GO:0008589), protein transport (GO:0015031), protein processing (GO:0016485), regulation of exocytosis (GO:0017157), dorsal/ventral neural tube patterning (GO:0021904), regulation of vesicle fusion (GO:0031338), axoneme assembly (GO:0035082), limb development (GO:0060173), cilium assembly (GO:0060271), cranial skeletal system development (GO:1904888), cell projection organization (GO:0030030)
GO Molecular Function (4): GTPase activity (GO:0003924), GTP binding (GO:0005525), nucleotide binding (GO:0000166), protein binding (GO:0005515)
GO Cellular Component (8): centriole (GO:0005814), ciliary transition zone (GO:0035869), ciliary basal body (GO:0036064), ciliary base (GO:0097546), cytoplasm (GO:0005737), cytoskeleton (GO:0005856), cilium (GO:0005929), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| cilium | 3 |
| regulation of vesicle-mediated transport | 2 |
| microtubule organizing center | 2 |
| intracellular membraneless organelle | 2 |
| endocardial cushion morphogenesis | 1 |
| cell adhesion involved in heart morphogenesis | 1 |
| cell-cell adhesion | 1 |
| vesicle-mediated transport | 1 |
| secretion by cell | 1 |
| vesicle fusion to plasma membrane | 1 |
| cell surface receptor signaling pathway | 1 |
| macromolecule localization | 1 |
| smoothened signaling pathway | 1 |
| regulation of signal transduction | 1 |
| transport | 1 |
| intracellular protein localization | 1 |
| establishment of protein localization | 1 |
| proteolysis | 1 |
| protein maturation | 1 |
| exocytosis | 1 |
| regulation of secretion by cell | 1 |
| dorsal/ventral pattern formation | 1 |
| neural tube patterning | 1 |
| vesicle fusion | 1 |
| regulation of organelle organization | 1 |
| microtubule bundle formation | 1 |
| cellular component assembly | 1 |
| cilium assembly | 1 |
| appendage development | 1 |
| axoneme assembly | 1 |
| intraciliary transport involved in cilium assembly | 1 |
| cilium organization | 1 |
| protein localization to cilium | 1 |
| organelle assembly | 1 |
| trans-Golgi to periciliary membrane compartment transport | 1 |
| plasma membrane bounded cell projection assembly | 1 |
| ciliary transition zone assembly | 1 |
| anatomical structure development | 1 |
| cellular component organization | 1 |
Protein interactions and networks
STRING
1345 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CPLANE2 | INTU | Q9ULD6 | 918 |
| CPLANE2 | WDPCP | O95876 | 858 |
| CPLANE2 | FUZ | Q9BT04 | 785 |
| CPLANE2 | RAB23 | Q9ULC3 | 608 |
| CPLANE2 | IFT43 | Q96FT9 | 578 |
| CPLANE2 | ARL13B | Q3SXY8 | 574 |
| CPLANE2 | IFT27 | Q9BW83 | 560 |
| CPLANE2 | IFT22 | Q9H7X7 | 547 |
| CPLANE2 | ARL3 | P36405 | 503 |
| CPLANE2 | KIF9 | Q9HAQ2 | 473 |
| CPLANE2 | DNAJC27 | Q9NZQ0 | 466 |
| CPLANE2 | TTBK2 | Q6IQ55 | 464 |
| CPLANE2 | TBC1D32 | Q96NH3 | 464 |
| CPLANE2 | RAB8A | P24407 | 456 |
| CPLANE2 | KIF24 | Q5T7B8 | 446 |
IntAct
27 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FUZ | CPLANE2 | psi-mi:“MI:0915”(physical association) | 0.800 |
| CPLANE2 | FUZ | psi-mi:“MI:0915”(physical association) | 0.800 |
| IMPDH2 | CPLANE2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| CPLANE2 | IMPDH2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| RND3 | CPLANE2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MSLN | CPLANE2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| CPLANE2 | TMEM14C | psi-mi:“MI:0915”(physical association) | 0.370 |
| CPLANE2 | FUZ | psi-mi:“MI:0914”(association) | 0.350 |
| INTU | CCNA2 | psi-mi:“MI:0914”(association) | 0.350 |
| CPLANE2 | PKP1 | psi-mi:“MI:0914”(association) | 0.350 |
| CPLANE2 | HSPA8 | psi-mi:“MI:0914”(association) | 0.350 |
| FUZ | UBL4A | psi-mi:“MI:0914”(association) | 0.350 |
| FUZ | HSPA8 | psi-mi:“MI:0914”(association) | 0.350 |
| FUZ | PRORP | psi-mi:“MI:0914”(association) | 0.350 |
| CPLANE2 | IMPDH2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FUZ | CPLANE2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CPLANE2 | RND3 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (20): RSG1 (Two-hybrid), INTU (Affinity Capture-MS), CDC37 (Affinity Capture-MS), PKP1 (Affinity Capture-MS), FUZ (Affinity Capture-MS), FUZ (Two-hybrid), FUZ (Affinity Capture-MS), INTU (Affinity Capture-MS), RSG1 (Two-hybrid), RSG1 (Two-hybrid), IMPDH2 (Two-hybrid), PKP1 (Affinity Capture-MS), FUZ (Affinity Capture-MS), RSG1 (Affinity Capture-MS), RSG1 (Affinity Capture-MS)
ESM2 similar proteins: A1L1L6, A2A825, A6QL63, C9J798, O14908, O43374, O94844, O95278, O95294, Q0P5N6, Q15126, Q1LVW0, Q2HJF8, Q2TBH1, Q3UMR5, Q3UNW5, Q4R4U1, Q5E9M9, Q5R5F8, Q5ZIW1, Q5ZM73, Q5ZM83, Q66JN8, Q6DFV5, Q6GQW0, Q6IE70, Q6NVC5, Q6NYU2, Q7TSA0, Q7Z6G3, Q8BG51, Q8BGF7, Q8BHT7, Q8CIW5, Q8IXI1, Q8IXI2, Q8JZN7, Q8VCX6, Q91XQ2, Q923S8
Diamond homologs: A2A825, B7ZTR0, Q66JN8, Q6GNL4, Q8IYK8, Q9BU20, Q9WTY2, P55041, Q8VEL9
SIGNOR signaling
2 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| “CPLANE complex” | “up-regulates activity” | CPLANE2 | binding |
| CPLANE2 | up-regulates | Cilium_assembly |
Disease & clinical
Clinical variants and AI predictions
ClinVar
64 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 54 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
799 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:16232598:CAG:C | acceptor_gain | 1.0000 |
| 1:16232599:A:T | acceptor_gain | 1.0000 |
| 1:16232642:CAAGC:C | acceptor_gain | 1.0000 |
| 1:16232643:AAGC:A | acceptor_gain | 1.0000 |
| 1:16232645:GC:G | acceptor_gain | 1.0000 |
| 1:16232646:CC:C | acceptor_gain | 1.0000 |
| 1:16232646:CCTGG:C | acceptor_loss | 1.0000 |
| 1:16232647:C:CC | acceptor_gain | 1.0000 |
| 1:16232648:T:C | acceptor_loss | 1.0000 |
| 1:16232650:G:C | acceptor_gain | 1.0000 |
| 1:16232653:A:AC | acceptor_gain | 1.0000 |
| 1:16232653:A:C | acceptor_gain | 1.0000 |
| 1:16232892:CCAG:C | donor_gain | 1.0000 |
| 1:16233015:TGC:T | acceptor_gain | 1.0000 |
| 1:16233608:TCA:T | donor_loss | 1.0000 |
| 1:16233610:A:AC | donor_gain | 1.0000 |
| 1:16233610:AC:A | donor_gain | 1.0000 |
| 1:16233611:C:CC | donor_gain | 1.0000 |
| 1:16233611:CC:C | donor_gain | 1.0000 |
| 1:16233611:CCG:C | donor_gain | 1.0000 |
| 1:16233611:CCGG:C | donor_gain | 1.0000 |
| 1:16233611:CCGGT:C | donor_gain | 1.0000 |
| 1:16233760:CAGCC:C | acceptor_gain | 1.0000 |
| 1:16233761:AGCC:A | acceptor_gain | 1.0000 |
| 1:16233762:GCC:G | acceptor_gain | 1.0000 |
| 1:16233763:CC:C | acceptor_gain | 1.0000 |
| 1:16233763:CCC:C | acceptor_gain | 1.0000 |
| 1:16233763:CCCT:C | acceptor_loss | 1.0000 |
| 1:16233764:CC:C | acceptor_gain | 1.0000 |
| 1:16233764:CCTAG:C | acceptor_loss | 1.0000 |
AlphaMissense
1668 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:16232908:G:C | F125L | 0.985 |
| 1:16232908:G:T | F125L | 0.985 |
| 1:16232910:A:G | F125L | 0.985 |
| 1:16232608:G:C | F143L | 0.983 |
| 1:16232608:G:T | F143L | 0.983 |
| 1:16232610:A:G | F143L | 0.983 |
| 1:16232994:A:G | W97R | 0.982 |
| 1:16232994:A:T | W97R | 0.982 |
| 1:16232510:T:A | K176I | 0.979 |
| 1:16232516:C:T | G174D | 0.977 |
| 1:16233673:C:A | K68N | 0.977 |
| 1:16233673:C:G | K68N | 0.977 |
| 1:16233706:C:A | K57N | 0.977 |
| 1:16233706:C:G | K57N | 0.977 |
| 1:16233674:T:A | K68M | 0.976 |
| 1:16233674:T:G | K68T | 0.975 |
| 1:16232607:A:G | S144P | 0.974 |
| 1:16233698:A:T | V60E | 0.974 |
| 1:16233692:C:T | G62E | 0.973 |
| 1:16233711:A:C | Y56D | 0.973 |
| 1:16236700:A:G | W15R | 0.973 |
| 1:16236700:A:T | W15R | 0.973 |
| 1:16232624:G:T | A138D | 0.969 |
| 1:16232625:C:G | A138P | 0.969 |
| 1:16233692:C:A | G62V | 0.969 |
| 1:16233693:C:A | G62W | 0.969 |
| 1:16233660:C:G | A73P | 0.968 |
| 1:16232522:A:T | V172D | 0.967 |
| 1:16232576:A:G | L154P | 0.967 |
| 1:16232609:A:G | F143S | 0.967 |
dbSNP variants (sampled 300 via entrez): RS1000774406 (1:16233069 G>A), RS1002216153 (1:16238719 A>T), RS1002548132 (1:16234911 A>C,T), RS1003222729 (1:16237203 C>T), RS1003253844 (1:16237398 C>G), RS1003620441 (1:16236721 C>A,G,T), RS1003804787 (1:16236254 TG>T), RS1004811596 (1:16237590 A>T), RS1005297324 (1:16231356 C>T), RS1006013203 (1:16232599 A>G), RS1006077833 (1:16238646 G>A,T), RS1006499222 (1:16239038 T>C,G), RS1006698518 (1:16238034 A>C), RS1007023294 (1:16237578 C>T), RS1007079833 (1:16237692 C>T)
Disease associations
OMIM: gene MIM:620487 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001277_7 | Liver enzyme levels (gamma-glutamyl transferase) | 3.000000e-19 |
| GCST008058_42 | Estimated glomerular filtration rate | 1.000000e-10 |
| GCST008059_245 | Estimated glomerular filtration rate | 1.000000e-09 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004532 | serum gamma-glutamyl transferase measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
18 total (human), top 18 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases methylation, increases expression | 2 |
| Silicon Dioxide | increases expression, decreases expression | 2 |
| Smoke | decreases expression, increases abundance, increases expression | 2 |
| beauvericin | affects cotreatment, increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| enniatins | affects cotreatment, increases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Decitabine | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Estradiol | affects cotreatment, decreases expression | 1 |
| Lead | affects expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.